BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26645582)

  • 1. Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas.
    Zhang L; Kundu S; Feenstra T; Li X; Jin C; Laaniste L; El Hassan TE; Ohlin KE; Yu D; Olofsson T; Olsson AK; Pontén F; Magnusson PU; Nilsson KF; Essand M; Smits A; Dieterich LC; Dimberg A
    Sci Signal; 2015 Dec; 8(406):ra125. PubMed ID: 26645582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
    Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
    Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
    Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of cycloxygenase-2 in astrocytoma: correlation with angiogenesis, tumor progression and survival.
    El-Sayed M; Taha MM
    Turk Neurosurg; 2011 Jan; 21(1):27-35. PubMed ID: 21294088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas.
    Ulbricht U; Brockmann MA; Aigner A; Eckerich C; Müller S; Fillbrandt R; Westphal M; Lamszus K
    J Neuropathol Exp Neurol; 2003 Dec; 62(12):1265-75. PubMed ID: 14692702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: correlation with IL-6, VEGF and microvessel morphometry.
    Piperi C; Samaras V; Levidou G; Kavantzas N; Boviatsis E; Petraki K; Grivas A; Barbatis C; Varsos V; Patsouris E; Korkolopoulou P
    Cytokine; 2011 Sep; 55(3):387-95. PubMed ID: 21684758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor (VEGF) and its two receptors in diffusely infiltrating astrocytomas and relationship to proliferative activity of tumor cells.
    Xiang F; Tanaka J; Takahashi J; Fukuda T
    Brain Tumor Pathol; 2001; 18(2):67-71. PubMed ID: 11908876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of angiogenesis and its correlation with vascular endothelial growth factor expression in astrocytic tumors.
    Gupta K; Radotra BD; Banerjee AK; Nijhawan R
    Anal Quant Cytol Histol; 2004 Aug; 26(4):223-9. PubMed ID: 15457675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotrophin is a driver of vascular abnormalization in glioblastoma.
    Zhang L; Dimberg A
    Mol Cell Oncol; 2016; 3(6):e1141087. PubMed ID: 28090572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
    Koyama-Nasu R; Haruta R; Nasu-Nishimura Y; Taniue K; Katou Y; Shirahige K; Todo T; Ino Y; Mukasa A; Saito N; Matsui M; Takahashi R; Hoshino-Okubo A; Sugano H; Manabe E; Funato K; Akiyama T
    Oncogene; 2014 Apr; 33(17):2236-44. PubMed ID: 23686309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
    Parthymou A; Lampropoulou E; Mikelis C; Drosou G; Papadimitriou E
    Eur J Cell Biol; 2008 Jan; 87(1):17-29. PubMed ID: 17881084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.
    Korkolopoulou P; Patsouris E; Konstantinidou AE; Pavlopoulos PM; Kavantzas N; Boviatsis E; Thymara I; Perdiki M; Thomas-Tsagli E; Angelidakis D; Rologis D; Sakkas D
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):267-78. PubMed ID: 15175080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
    Erdamar S; Bagci P; Oz B; Dirican A
    J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis.
    Sonoda Y; Kanamori M; Deen DF; Cheng SY; Berger MS; Pieper RO
    Cancer Res; 2003 Apr; 63(8):1962-8. PubMed ID: 12702589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P; Xu L; Pan S; Brekken RA; Yang ST; Whitaker GB; Nagane M; Thorpe PE; Rosenbaum JS; Su Huang HJ; Cavenee WK; Cheng SY
    Cancer Res; 2001 Dec; 61(23):8569-77. PubMed ID: 11731444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.
    Lamszus K; Ulbricht U; Matschke J; Brockmann MA; Fillbrandt R; Westphal M
    Clin Cancer Res; 2003 Apr; 9(4):1399-405. PubMed ID: 12684411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis in malignant gliomas.
    Plate KH; Risau W
    Glia; 1995 Nov; 15(3):339-47. PubMed ID: 8586468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of tissue endostatin in human malignant gliomas.
    Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
    Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)?
    Mathivet T; Mazot P; Vigny M
    Cell Signal; 2007 Dec; 19(12):2434-43. PubMed ID: 17904822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.